Benzinga | Jun 15, 2021 07:17AM EDT

Renalytix AI Q3 EPS $(0.12) Beats $(0.15) Estimate, Sales $619.00K Beat $610.00K Estimate

Renalytix AI (NASDAQ:RNLX) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 20 percent. The company reported quarterly sales of $619.00 thousand which beat the analyst consensus estimate of $610.00 thousand by 1.48 percent.